您的位置: 首页 > 农业专利 > 详情页

Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent
专利权人:
PACIRA PHARMACEUTICALS; INC.
发明人:
Louie Daniel Garcia,Lois Gibson,William Joseph Lambert,Benjamin W. Li,Liangjin Zhu
申请号:
US13786323
公开号:
US10028911B2
申请日:
2013.03.05
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Disclosed is are formulations comprising a multivesicular liposome and MTX, the administration of which results in a Cmax of MTX between 5% and 50% of the Cmax of an immediate release dosage form of MTX, the duration of which lasts from about 1 to about 30 days. Also disclosed are methods of treating autoimmune diseases and cancer by administering these formulations of MTX.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充